Stay updated with breaking news from Michael Thorpy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Michael Thorpy, MD, professor of neurology, Albert Einstein College of Medicine, discusses promising pharmacological treatments for patients with idiopathic hypersomnia.
Axsome Therapeutics, Inc. , a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders, today announced five presentations, including two featured oral plenary presentations, on...
Axsome will unveil data demonstrating solriamfetol's ability to enhance cognitive functioning in patients with OSA and narcolepsy.
Here are some updates from the world of psychiatry throughout the month of March.
The treatment significantly reduced the frequency of cataplexy attacks in patients with narcolepsy compared with placebo.